Original news and analysis on international IP policy
The number of candidates to be the next director general of the World Health Organization was reduced from five to three tonight, with Ethiopia, Pakistan and the United Kingdom still in the running. But in a race as unpredictable as this one, delegates and observers in the hallway were both surprised and not surprised by the outcome as Europe fell to the bottom of the list.
World Health Organization members took the first step toward choosing the next director general of the UN health agency today as they narrowed the candidates to five. There will be interviews held with the remaining candidates tomorrow, after which the list will be reduced to three until the May World Health Assembly.
At the opening of the World Health Organization Executive Board meeting today, a call by India for an agenda item on the report of the United Nations Secretary-General’s High-Level Panel on Access to Medicines was denied. Meanwhile, WHO’s director general underlined the success of the organisation over the last year, including new financing arrangements with industry groups to finance the WHO Prequalification Programme. But all eyes are riveted to the election process for the new WHO director general, as three out of the six candidates are expected to be short-listed this week.
Effective laws, including those around intellectual property rights, and an enabling legal environment, are as essential to a healthy society as clean water, a group made up of a representative of the World Health Organization, academics and a legal expert for a civil society group, have asserted while launching a key report.
Although the main governing body of the World Health Organization is the annual World Health Assembly held in May, many decisions are made at the annual January session of the WHO Executive Board. Among the topics to be discussed next week are the election of a new director general, antimicrobial resistance, the financing of research and development for health products.
The World Health Organization recently published its analysis about the public health implications of the Nagoya Protocol on genetic resources access and benefit-sharing, and in particular how it affects the sharing of pathogens, like influenza viruses. The findings are set to be discussed at this month’s WHO Executive Board meeting. Also to be discussed is an experts group review of the WHO pandemic influenza framework, and in particular its conclusion that the framework should be amended to match scientific progress.
A recently published book by a high-impact public health advocate provides new analysis on the use of flexibilities in international trade law relating to intellectual property rights aimed at advancing discussions on solutions to high drug prices worldwide.
Hundreds of thousands of people visited articles on Intellectual Property Watch last year, and we published nearly 1,000 original articles. The year’s most-visited articles reflected a mix of new ideas and policies worldwide and some recurring issues, with especially heavy attention on stories involving India.
One of the key questions around the impact of patents on health and innovation is what is the appropriate level of protection for companies innovating, says Dr. Marie-Paul Kieny, assistant director-general, Health Systems and Innovation, at the World Health Organization.
As a new year dawns, a lot of movement has been observed in the pharmaceutical industry with new key players taking the lead. Meanwhile, new delegates are covering IP issues in Geneva, and coordination of regional groups at the World Intellectual Property Organization makes its usual yearly shift for 2017. The copyright industry also saw major changes, and law offices have been busy hiring new partners.
The United Nations General Assembly this month is considering a resolution committing to elevate health issues to the highest levels of foreign policy. The resolution includes references and commitments related to dozens of existing instruments and tools aimed at improving health, including a full range of those on access to medicines, such as patent flexibilities under trade rules, and the recent report of the UN Secretary-General’s High-Level Panel on access to medicines and innovation.
The Executive Board of UNITAID yesterday adopted a resolution on the use of the intellectual property flexibilities enshrined in the global trading system allowing developing countries to facilitate access to affordable medicines.